top of page


FDA Approves Simtriyo (Centanafadine) for ADHD
Introduction ADHD is a neurodevelopmental disorder that can affect individuals throughout childhood and adulthood. It is characterised by persistent difficulties with attention, impulse control and hyperactivity, which may interfere with everyday functioning. Common symptoms include difficulty concentrating, forgetfulness, disorganisation, restlessness and trouble completing tasks. These challenges can affect academic performance, relationships, social interactions and profes

Dr. Geetika Gupta
2 hours ago7 min read
Â
Â
bottom of page